#192 Debate on First-Line Medications for Diabetes

#192 Debate on First-Line Medications for Dia...

Up next

#222 AFib Stroke Prevention: WATCHMAN, DOACs, and the CHAMPION-AF Trial | Beyond Journal Club Segment with NEJM Group

If your patient asks you about a left atrial appendage closure device, what should you tell them? In the latest episode of the Beyond Journal Club podcast from CORE IM and NEJM Group, the hosts will help you: Understand the trade-offs: stroke prevention, bleeding, procedural risk ...  Show more

#221 Colon Cancer Screening After Age 75 | 5 Pearls Segment Part 3

“Should you stop screening for colorectal cancer (CRC) at 75?” This episode explores how to individualize screening decisions based on life expectancy, prior colonoscopy findings, and procedural risks. Learn how to navigate these nuanced conversations, avoid age-based assumptions ...  Show more

Recommended Episodes

Comparison of Oral Medications for Type-2 Diabetes *ACPE-Accredited*
CorConsult Rx: Evidence-Based Medicine and Pharmacy

On this episode, we compare and contrast oral medications that can be used to manage patients with type-2 diabetes. We review metformin, SGLT2 inhibitors, oral semaglutide, sulfonylureas, TZDs, and more. 

Cole and I are happy to share that our listeners can claim ACPE-a ...

  Show more

8: USMLE and COMLEX Prep: Side Effects of Diabetes Medications
Board Rounds Prep for USMLE and COMLEX

Session 08 Step 1 and Level 1 love to test the mechanisms or side effects of medications that treat diabetes. Follow along to test your knowledge of diabetic medications and side effects. Once again, we're joined by Dr. Andrea Paul, Chief Medical Officer at Board Vitals. Reminder ...  Show more

#279 - AMA #53: Metabolic health & pharmacologic interventions: SGLT-2 inhibitors, metformin, GLP-1 agonists, and the impact of statins
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/?utm_source=podcast-feed ...

  Show more